NutryFarm Says Key Shareholder Documents Remain Outstanding in Investigation
Bitget2026/10/27 10:03- NutryFarm International is reviewing shareholders' October 26, 2026, response as its investigation into voting rights, share pledges and restructuring arrangements continues.
- Requisitioning shareholders questioned Niu Liming's authority to exercise voting rights on behalf of Jia Lijie.
- They provided a March 2, 2025, agreement for Tianci International to transfer 10,000,000 shares to Raffles Financial.
- Shareholders requested a substantive response by October 30, 2026, reiterating plans to convene a special general meeting on November 13, 2026.
- Trading in the company's securities on SGX-ST has been voluntarily suspended since April 11, 2022.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
BUZZ - Rocket Lab’s stock falls as quarterly loss exceeds expectations
BUZZ-Take-Two shares rise after raising annual revenue and profit forecasts
Itaúsa Q3 2026 recurring net profit rises 25% to R$ 5.06 billion year-on-year
The US FDA requires semaglutide, tirzepatide, and other GLP-1 drugs to include new warnings about the risk of eye disease.
NAION is an eye disease that can cause sudden, painless loss of vision, with some patients potentially experiencing permanent visual impairment. The drugs involved include products from Eli Lilly and Novo Nordisk. According to analysts at Citi, the incidence of NAION is relatively low, and given the significant benefits of GLP-1 drugs in weight control and blood sugar management, the actual impact on prescription behavior is expected to be limited. On Monday, the stock prices of Eli Lilly and Novo Nordisk increased, with the news not causing any significant impact on their share prices.
Crypto prices
More
